Zobrazeno 1 - 10
of 131
pro vyhledávání: '"V Vlahov"'
Autor:
Andrey A. Sharov, Andrei N. Mardaryev, Nikola V. Vlahov, Mohammed I. Ahmed, Michael Y. Fessing, Natalia V. Botchkareva, Jason H. Gill
Publikováno v:
The FASEB Journal. 24:3869-3881
The hair follicle is a cyclic biological system that progresses through stages of growth, regression, and quiescence, which involves dynamic changes in a program of gene regulation. Micro-RNAs (miRNAs) are critically important for the control of gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9227712f04d5c2a2211c18bd0c5af68e
https://doi.org/10.1096/fj.10-160663
https://doi.org/10.1096/fj.10-160663
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 43:457-462
Background: The choice of an appropriate reference product is still a problem within the European Union. When no direct comparisons between originator products in different countries are available, registration authorities are sometimes only prepared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::510c1b76c010e4eb7e1dc915ab6f980f
https://doi.org/10.5414/cpp43457
https://doi.org/10.5414/cpp43457
Autor:
Rossen Koytchev, V Vlahov, E. Rehak, U. Thyroff-Friesinger, R.-G. Alken, Valentin Kirkov, R. Kaneva
Publikováno v:
European Journal of Clinical Pharmacology. 54:469-474
The aim of the present paper was to compare the pharmacokinetics of metoprolol in homozygous Caucasian volunteers for the wild-type CYP2D6 allele (CYP2D6*1/CYP2D6*1) and heterozygous (CYP2D6*1/CYP2D6*4) Caucasians.Thirty-six unrelated healthy male Ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::620298eb2e2c10d32bae2499bf2b169f
https://doi.org/10.1007/s002280050495
https://doi.org/10.1007/s002280050495
Publikováno v:
Pharmacogenetics. 6:67-72
The role of genetic factors in the pathogenesis of agranulocytosis was investigated in agranulocytosis patients by phenotyping for N-acetyltransferase and glucose-6-phosphate polymorphism; by typing for gene products of the major histocompatability c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6c83cf68cf707659364282b86b8e54
https://doi.org/10.1097/00008571-199602000-00005
https://doi.org/10.1097/00008571-199602000-00005
Background: Trapidil is an inhibitor of phosphodiesterase I-IV with resulting positive lusitropic, vasodilating, and antiplatelet effects. Hypothesis: This study was undertaken to compare the antianginal efficacy of trapidil with that of isosorbide d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5832d6e20af7b0bacf963ed7dc2bc54
https://europepmc.org/articles/PMC6655814/
https://europepmc.org/articles/PMC6655814/
Autor:
G Muirhead, R Portmann, I Viachki, N Bacracheva, E Weidekamm, V Vlahov, K Stoeckel, W L Hayton
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:2375-2380
Patients with biliary tract infections received 800 mg of fleroxacin orally once daily on five consecutive days; cholecystectomy was on day 3. Starting on the day when dose 5 was administered, serial blood and T-drain bile samples were taken for 72 h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c67523669a291d24d79f0f25ee8cb6d
https://doi.org/10.1128/aac.34.12.2375
https://doi.org/10.1128/aac.34.12.2375
Autor:
B Gawronska-Szklarz, M van der Meer, N Bacratcheva, Rossen Koytchev, B Giesel, J Wojcicki, A Mrozikiewiczs, R G Alken, V Vlahov
Publikováno v:
International journal of clinical pharmacology and therapeutics. 41(3)
Background The aim of the present trial was to evaluate the efficacy of a combined product in the treatment of common cold and to examine the contribution of the separate components. In the published literature there is conflicting data on the effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47e8ef59ac1aae0c4568ecb9ce13c752
https://pubmed.ncbi.nlm.nih.gov/12665160
https://pubmed.ncbi.nlm.nih.gov/12665160
Autor:
N, Bacracheva, N, Tyutyulkova, A, Drenska, J, Gorantcheva, S, Schinzel, T, Scholl, A, Stoinov, I, Tchakarski, J, Tentcheva, V, Vlahov
Publikováno v:
International journal of clinical pharmacology and therapeutics. 35(7)
Metamizol (dipyrone) is hydrolyzed in the gastrointestinal tract to the pharmacologically active metabolite 4-methyl-amino-antipyrine (4-MAA), which is transformed by both, oxidation to 4-formyl-amino-antipyrine (4-FAA) and demethylation to 4-amino-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::40d48d294b7c1b0eee6b1c5caa76adc9
https://pubmed.ncbi.nlm.nih.gov/9247840
https://pubmed.ncbi.nlm.nih.gov/9247840
Autor:
N. Bacracheva, V. Vlahov
Publikováno v:
European Journal of Clinical Pharmacology. 48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56f681bf50b50465ada15e5082c20ef4
https://doi.org/10.1007/bf00202178
https://doi.org/10.1007/bf00202178
Publikováno v:
Arzneimittel-Forschung. 45(3)
The bioavailability of the four metabolites of metamizole (CAS 68-89-3), 4-methyl-amino-antipyrine (4-MAA), 4-formyl-amino-antipyrine (4-FAA), 4-amino-antipyrine (4-AA) and 4-acetyl-amino-antipyrine (4-AcAA) was compared after oral administration of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e187dd1228eb596c0d6d62c95efe75f7
https://pubmed.ncbi.nlm.nih.gov/7741785
https://pubmed.ncbi.nlm.nih.gov/7741785